Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Avismo Ventures is a venture capital firm dedicated to advancing generative conversational AI specifically for the health and life sciences sectors. Founded with the mission to enhance performance and engagement in these critical fields, the firm operates globally, targeting innovative startups that align with its investment thesis.
The organization currently focuses on seed to Series B stages, providing not only capital but also strategic advisory services to empower entrepreneurs. Avismo Ventures has established a strong presence in the healthcare sector, collaborating with major organizations to improve AI interactions and solutions.
With a commitment to developing domain-specific AI agents, Avismo Ventures has built a portfolio that reflects its dedication to the health and life sciences industries. Their partnerships with notable healthcare entities underscore their influence and reach within this specialized market.
Avismo Ventures invests in the health and life sciences sectors, with a particular emphasis on generative conversational AI. The firm targets startups at the seed, Series A, and Series B stages, providing both capital and strategic advisory services. Their investment strategy includes a focus on developing domain-specific AI agents that enhance Healthcare Professional (HCP) engagement and training.
The firm’s offerings extend to workforce and student training within institutions and health systems, addressing the complexities of AI integration in healthcare. Avismo Ventures seeks to partner with founders who are innovating in AI and healthcare, looking for teams that demonstrate a clear vision and capability to execute their ideas effectively.
Avismo Ventures has collaborated with several notable healthcare organizations, highlighting its commitment to enhancing AI interactions within the sector. Their portfolio includes partnerships with:
These collaborations reflect Avismo Ventures' focus on improving healthcare outcomes through innovative AI solutions and underscore their role in the evolving landscape of health and life sciences.
Startups interested in pitching to Avismo Ventures should submit their proposals through the contact form on their website. A well-structured pitch deck that outlines the business model, market opportunity, and team qualifications is essential. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
What are Avismo Ventures' investment criteria?
Avismo Ventures focuses on startups within the health and life sciences sectors, particularly those developing generative conversational AI solutions. They target seed to Series B stages and look for innovative teams with a clear vision.
How can startups apply or pitch to Avismo Ventures?
Startups can apply by visiting the Avismo Ventures website and submitting their pitch through the provided contact form. They encourage detailed presentations that outline the startup's vision, market potential, and team capabilities.
What makes Avismo Ventures different from other investors?
Avismo Ventures specializes in generative conversational AI for health and life sciences, providing not only capital but also strategic advisory services to enhance startup growth. Their deep industry connections and focus on domain-specific solutions set them apart.
What is the geographic scope of Avismo Ventures?
Avismo Ventures operates globally, seeking innovative startups from various regions that align with their investment focus in health and life sciences.
What kind of post-investment involvement can founders expect?
Avismo Ventures offers operational support, mentorship, and access to their extensive network within the healthcare sector, helping portfolio companies navigate challenges and scale effectively.
What is the typical check size for investments?
While specific check sizes are not disclosed, Avismo Ventures invests at the seed to Series B stages, indicating a range that typically aligns with early-stage funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.